Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 To cleave or not to cleave: role of ADAM17 in cell proliferation in PKD.

× No keyword cloud information.

14 in total

1. Drug evaluation: apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis.

Authors: Mohamed M Thabet; Tom W J Huizinga
Journal: Curr Opin Investig Drugs Date: 2006-11

2. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17.

Authors: Ci-Di Chen; Sonia Podvin; Earl Gillespie; Susan E Leeman; Carmela R Abraham
Journal: Proc Natl Acad Sci U S A Date: 2007-12-03 Impact factor: 11.205

3. Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

Authors: Jan M Williams; Jin Zhang; Paula North; Steven Lacy; Michael Yakes; Annette Dahly-Vernon; Richard J Roman
Journal: Am J Physiol Renal Physiol Date: 2011-01-12

4. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.

Authors: Monika Göoz; Pal Göoz; Louis M Luttrell; John R Raymond
Journal: J Biol Chem Date: 2006-05-31 Impact factor: 5.157

5. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach.

Authors: Alexandre Lautrette; Shunqiang Li; Rohia Alili; Susan W Sunnarborg; Martine Burtin; David C Lee; Gérard Friedlander; Fabiola Terzi
Journal: Nat Med Date: 2005-07-24 Impact factor: 53.440

6. Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement.

Authors: Mamon Dey; Aleksander Baldys; Dezmond B Sumter; Pal Göoz; Louis M Luttrell; John R Raymond; Monika Göoz
Journal: J Pharmacol Exp Ther Date: 2010-06-21 Impact factor: 4.030

To cleave or not to cleave: role of ADAM17 in cell proliferation in PKD.

1. Drug evaluation: apratastat, a novel TACE/MMP inhibitor for rheumatoid arthritis.

2. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17.

3. Evaluation of metalloprotease inhibitors on hypertension and diabetic nephropathy.

4. 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells.

5. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach.

6. Bradykinin decreases podocyte permeability through ADAM17-dependent epidermal growth factor receptor activation and zonula occludens-1 rearrangement.

Review 7. Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells.

Review 8. Drug insight: tumor necrosis factor-converting enzyme as a pharmaceutical target for rheumatoid arthritis.

Review 9. Epidermal growth factors in the kidney and relationship to hypertension.

Review 10. Role of epidermal growth factor receptor in acute and chronic kidney injury.